Create Free Account

By creating account you will get access to hot stocks & personalised emails

Apiam Animal Health Ltd

Consumer Cyclical AU AHX

0.375AUD
-0.01(2.60%)

Last update at 2024-12-19T01:39:00Z

Day Range

0.380.39
LowHigh

52 Week Range

0.220.56
LowHigh

Fundamentals

  • Previous Close 0.39
  • Market Cap70.27M
  • Volume9512
  • P/E Ratio12.83
  • Dividend Yield4.76%
  • EBITDA19.60M
  • Revenue TTM204.66M
  • Revenue Per Share TTM1.15
  • Gross Profit TTM 39.04M
  • Diluted EPS TTM0.03

Analyst Recommendations

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Income before tax 3.17M 6.47M 7.04M 6.07M 4.57M
Minority interest 0.11M 0.10M 1.00M 1.02M 0.76M
Net income 2.28M 4.64M 5.08M 4.17M 3.17M
Selling general administrative 82.84M 61.96M 43.26M 37.68M 33.09M
Selling and marketing expenses - - - - -
Gross profit 121.88M 96.30M 70.26M 63.00M 55.12M
Reconciled depreciation 10.23M 8.36M 6.34M 5.85M 3.15M
Ebit 6.35M 7.64M 7.85M 7.04M 5.64M
Ebitda 16.57M 16.00M 14.19M 12.90M 8.79M
Depreciation and amortization 10.23M 8.36M 6.34M 5.85M 3.15M
Non operating income net other - - - - -
Operating income 6.57M 7.78M 8.21M 7.66M 5.64M
Other operating expenses 184.82M 149.02M 118.03M 111.01M 106.05M
Interest expense 3.18M 1.17M 0.81M 0.98M 1.07M
Tax provision 0.99M 1.93M 2.04M 1.77M 1.42M
Interest income 3.72M 1.48M 1.10M 1.32M 1.12M
Net interest income -3.77400M -1.57000M -1.17600M -0.98000M -1.07400M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 0.99M 1.93M 2.04M 1.77M 1.42M
Total revenue 191.76M 157.06M 126.18M 118.33M 111.72M
Total operating expenses 115.31M 86.71M 61.98M 55.23M 49.45M
Cost of revenue 69.88M 60.76M 55.92M 55.34M 56.60M
Total other income expense net 0.37M -1.54400M -0.06500M -0.33300M -1.07400M
Discontinued operations - - - - -
Net income from continuing ops 2.17M 4.54M 5.00M 4.29M 3.15M
Net income applicable to common shares 2.28M 4.64M 5.08M 4.17M 3.17M
Preferred stock and other adjustments - - - - -
Breakdown 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Type yearly yearly yearly yearly yearly
Date 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Total assets 255.78M 246.04M 199.04M 156.63M 141.03M
Intangible assets 17.48M 18.30M 13.25M 6.45M 4.53M
Earning assets - - - - -
Other current assets 2.24M -0.00100M 0.32M 0.17M 0.07M
Total liab 133.75M 128.14M 90.36M 75.77M 72.51M
Total stockholder equity 122.02M 117.87M 108.55M 79.86M 67.49M
Deferred long term liab - 3.31M 1.52M 1.98M 2.13M
Other current liab 19.98M 1.22M 0.50M 0.19M 4.15M
Common stock 135.77M 134.84M 127.25M 101.01M 91.11M
Capital stock 135.77M 134.84M 127.25M 101.01M 91.11M
Retained earnings 18.47M 15.34M 13.76M 11.64M 9.49M
Other liab - 4.77M 4.67M 2.08M 1.30M
Good will 150.12M 145.31M 113.58M 88.62M 79.75M
Other assets 0.00000M 3.60M 5.94M 5.47M 5.57M
Cash 1.76M 3.60M 2.85M 2.15M 2.51M
Cash and equivalents - - - - -
Total current liabilities 33.74M 33.27M 28.77M 24.37M 26.20M
Current deferred revenue 1.77M 17.81M 16.06M 12.21M 10.38M
Net debt 100.02M 94.42M 60.55M 52.89M 48.59M
Short term debt 5.91M 7.92M 6.47M 5.73M 6.08M
Short long term debt - 2.93M 2.91M 2.82M 3.40M
Short long term debt total 101.78M 98.03M 63.39M 55.04M 51.10M
Other stockholder equity -0.00000M -150.17600M -141.00500M -112.60600M -100.51700M
Property plant equipment - 43.81M 31.64M 24.54M 19.80M
Total current assets 32.51M 34.73M 35.88M 33.31M 33.36M
Long term investments 0.27M 0.27M 0.27M 0.22M 0.14M
Net tangible assets - -42.43300M -16.76400M -13.23500M -14.66000M
Short term investments - - - - -
Net receivables 13.37M 13.96M 13.62M 13.54M 11.87M
Long term debt 64.27M 66.07M 39.16M 34.89M 33.56M
Inventory 15.14M 15.47M 17.78M 16.04M 17.67M
Accounts payable 6.08M 6.32M 5.74M 6.25M 5.58M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -32.21200M -32.30800M -32.45500M -32.79100M -33.10400M
Additional paid in capital - - - - -
Common stock total equity - - - - 91.11M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 17.48M - - - 0.12M
Deferred long term asset charges - - - - -
Non current assets total 223.27M 211.31M 163.17M 123.32M 107.66M
Capital lease obligations 37.51M 29.03M 21.31M 17.34M 14.14M
Long term debt total - 90.11M 56.92M 49.31M 45.02M
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Investments -40.57000M -32.48300M -16.62100M -15.00100M -3.06700M
Change to liabilities -0.87100M -0.16900M 0.63M -2.30100M -2.44400M
Total cashflows from investing activities -40.57000M -32.48300M -16.62100M -15.00100M -3.06700M
Net borrowings 24.16M 1.29M -1.24800M 9.17M -0.48400M
Total cash from financing activities 23.49M 18.14M 2.57M 8.13M -1.38000M
Change to operating activities 1.19M 0.63M 0.36M 0.50M -0.09600M
Net income 2.28M 4.64M 5.04M 4.09M 3.17M
Change in cash 0.33M 0.69M -0.35900M 0.64M 0.44M
Begin period cash flow 2.85M 2.15M 2.51M 1.87M 1.44M
End period cash flow 3.17M 2.85M 2.15M 2.51M 1.87M
Total cash from operating activities 17.41M 15.04M 13.69M 7.51M 4.88M
Issuance of capital stock - 20.25M 6.00M - -
Depreciation 9.82M 8.36M 6.43M 6.06M 3.15M
Other cashflows from investing activities -32.36500M 0.04M -11.64000M -13.01500M -0.23500M
Dividends paid 0.67M 2.36M 1.94M 1.18M 1.02M
Change to inventory 1.17M -0.66800M 1.89M -5.25700M 0.55M
Change to account receivables 2.03M 1.35M -1.51900M 3.40M 0.73M
Sale purchase of stock 0.00000M -1.06900M -0.30000M -0.30000M -
Other cashflows from financing activities 34.28M 28.01M 7.83M 19.48M 14.94M
Change to netincome 2.79M 0.60M 0.53M -0.20800M 0.14M
Capital expenditures 8.21M 4.86M 4.98M 1.99M 2.57M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 3.19M 0.68M 0.38M -1.85700M -116.22300M
Stock based compensation 0.57M 0.77M 0.34M 0.07M -
Other non cash items 5.31M 2.04M 2.23M -2.64700M -6.31200M
Free cash flow 9.20M 10.17M 8.71M 5.52M -2.56600M

Peer Comparison

Sector: Consumer Cyclical Industry: Personal Services

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
AHX
Apiam Animal Health Ltd		 -0.01 2.60% 0.38 12.83 - 0.34 0.63 0.86 7.49
PFP
Propel Funeral Partners Ltd		 -0.12 2.07% 5.67 42.07 28.90 3.88 2.31 4.54 18.64
SHJ
Shine Corporate Ltd		 -0.02 2.22% 0.88 22.13 - 0.77 0.56 1.04 6.22
MFD
Mayfield Childcare Ltd		 - -% 0.49 - 8.02 0.41 0.50 2.39 12.86
MPA
Mad Paws Holdings Ltd		 -0.003 4.29% 0.07 - - 0.99 1.53 1.07 -3.8968

Reports Covered

Stock Research & News

View All

Profile

Apiam Animal Health Limited, a vertically integrated animal health company, provides veterinary products and services to production and companion animals, and equine in Australia. It operates through three segments: Clinical Vet Services, Feedlots, and Pigs. The company engages in the provision of veterinary wholesale, laboratories, warehousing and logistics, and other ancillary services. It also offers companion animal, dairy, swine and poultry, beef feedlot, equine, sheep, and genetic services, as well as diagnostics and custom vaccines. In addition, the company provides telemedicine, remote video, benchmarking, database analysis, and herd management software; and herd health management services through eCommerce. It provides its services through animal veterinary clinics. Apiam Animal Health Limited was founded in 1998 and is based in Bendigo, Australia.

Apiam Animal Health Ltd

27-33 Piper Lane, Bendigo, VIC, Australia, 3550

Key Executives

Name Title Year Born
Dr. Christopher Irwin Richards B.Sc., BSc, BVSc, M.A.I.C.D. MD & Exec. Director NA
Mr. Matthew Brian White BAcc, CPA Chief Financial Officer NA
Mr. Brian Scutt M.B.A. Chief Operating Officer NA
Mr. Matt Gallagher FCIS, L.L.M. Gen. Counsel NA
Ms. Renee Waters B.Sc. Chief People Officer NA
Ms. Eryl Baron AGIA, B.A., C.A., CA Company Sec. NA
Dr. Christopher Irwin Richards B.Sc., BSc, BVSc, M.A.I.C.D. MD & Executive Director NA
Mr. Matt Gallagher FCIS, L.L.M. General Counsel NA
Ms. Eryl Baron AGIA, B.A., C.A. Company Secretary NA
Dr. Christopher Irwin Richards B.Sc., BSc, BVSc, M.A.I.C.D. MD & Executive Director NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.

Our Company

Useful Links

Contact Us

ISO Certified Market Research

Kalkine Solutions Private Limited, authorized representative of Kalkine Pty Ltd, holds ISO 27001:2022 certification bearing Certificate No.- IC-IS-2404072

Our Company

Useful Links

Contact Us

Disclaimer

The information given by Kalkine Pty Ltd ABN34 154 808 312 (Australian Financial Services License Number 425376) on this website is general information or advice only.

It does not take into account any of your personal objectives, circumstances or needs. Choosing an investment is an important decision. If you do not feel confident making a decision based on the recommendations Kalkine has made in our reports, you should consider obtaining personal advice from an authorised adviser.

There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. Terms & Conditions have been provided for our services, please go through them and also read our Financial Services Guide.

Our website may contain information on past performance of particular investments. Past performance is not an indicator of future performance. Hypothetical returns may not reflect actual performance. Any displays of potential investment opportunities are for sample purposes only and may not actually be available to investors.

The information on the website does not constitute an offer to sell securities or a solicitation of an offer to buy securities. Our reports contain general recommendations to invest in securities.

Copyright 2024 Krish Capital Pty. Ltd. All rights reserved. No part of this website, or its content, may be reproduced in any form without our prior consent.